Cellectar Biosciences Inc (NASDAQ: CLRB) Shares Are Up 0.36% Year To Date.

In the latest trading session,, 0.46 million Cellectar Biosciences Inc (NASDAQ:CLRB) shares changed hands as the company’s beta touched 1.00. With the company’s most recent per share price at $2.78 changed hands at -$0.12 or -4.14% at last look, the market valuation stands at $99.66M. CLRB’s current price is a discount, trading about -60.07% off its 52-week high of $4.45. The share price had its 52-week low at $1.56, which suggests the last value was 43.88% up since then. When we look at Cellectar Biosciences Inc’s average trading volume, we note the 3-month average coming to 751.50K.

Cellectar Biosciences Inc (NASDAQ:CLRB) trade information

Instantly CLRB was in red as seen in intraday trades today. With action -14.72%, the performance over the past five days has been red. The drop to weekly highs of 3.42 subtracted -4.14% to the stock’s daily price. The company’s shares are showing year-to-date upside of 0.36%, with the 5-day performance at -14.72% in the red. However, in the 30-day time frame, Cellectar Biosciences Inc (NASDAQ:CLRB) is -15.76% down.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Cellectar Biosciences Inc (CLRB) estimates and forecasts

Data shows that the Cellectar Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 4.91% over the past 6 months, a 40.95% in annual growth rate that is considerably higher than the industry average of 12.90%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 43.13%. The 2024 estimates are for Cellectar Biosciences Inc earnings to increase by 53.46%.

CLRB Dividends

Cellectar Biosciences Inc is expected to release its next quarterly earnings report in July.